ADT plus radiotherapy boosts survival in metastatic prostate cancer

For men with metastatic prostate cancer, overall survival is improved for those treated with androgen deprivation therapy and prostate radiotherapy, compared with ADT alone, according to a study published online in the Journal of Clinical Oncology.
Cancer Therapy AdvisorComment on this story